Electrical Impedance Tomography-Based Prognostic Model for ARDS

NCT ID: NCT06967207

Last Updated: 2025-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

625 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-15

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multicenter, prospective, observational study aims to develop and validate an EIT-based prognostic model for ARDS. By focusing on the pathophysiological characteristics of ARDS and the causes of ventilator-induced lung injury, the investigators intend to establish a prognostic model that reveals lung injury and heterogeneity, enabling risk stratification and guiding individualized treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome (ARDS) Ventilator-induced Lung Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ARDS Patients for Training cohort

Training cohort

Not applicable- observational study

Intervention Type OTHER

Not applicable- observational study

ARDS Patients for Validation cohort

Validation cohort

Not applicable- observational study

Intervention Type OTHER

Not applicable- observational study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Not applicable- observational study

Not applicable- observational study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Meet the new 2023 ARDS global definition;
2. Age 18-80 years

Exclusion Criteria

1. Expected death within 24 hours of screening;
2. Metastatic cancer (active malignancy with distant metastases);
3. Severe psychiatric disorders;
4. Pregnancy or postpartum status;
5. Pneumothorax or moderate to large pleural effusion without adequate drainage;
6. Chronic respiratory failure;
7. Patients with pulmonary embolism or pulmonary hypertension;
8. Heart failure patients: EF \<50% or NYHA class III or IV;
9. Patient/family refusal to participate;
10. Participation in another interventional trial within 3 months prior to enrollment
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

XiaoJing Zou,MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

XiaoJing Zou,MD

MD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Critical Care Medicine, Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

Site Status RECRUITING

Department of Critical Care Medicine, Renmin Hospital of Wuhan University

Wuhan, Hubei, China

Site Status RECRUITING

Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Department of

Wuhan, Hubei, China

Site Status RECRUITING

Department of Emergency, Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaojing Zou Zou

Role: CONTACT

84+13995518630

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yiyu Deng

Role: primary

86+15013287340

Liying Zhan

Role: primary

+8615327408448

Xiaojing Zou

Role: primary

86+13995518630

Zhenju Song

Role: primary

86+13816607453

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EIT20250331

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lung EIT Image Guide Ventilation in ARDS
NCT07309783 NOT_YET_RECRUITING NA